- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in us fda
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg
Read More
Cipla Receives Final Approval For Generic Version Of Shire’s Firazyr®
Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Read More
Glenmark Stock Up After US Approval To Its Savella Generic
Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points
Read More
US Bans Divi's Factory, Shares Hit 3-year Low
US health regulators have banned a drug production site in India belonging to Divi's Laboratories Ltd due to manufacturing violations, sending the company's shares down to a near three-year low on Wednesday
Read More
Sun Pharma Says FDA To Lift Ban On Mohali Drug Plant
Sun Pharmaceutical Industries said on Tuesday that US regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years
Read More
US FDA Finds Quality Control Problems At Sun Pharma's Halol Plant
The US Food and Drug Administration has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows
Read More
FDA Halts Sale Of Some Antibacterial Hand, Body Wash Products
Johnson & Johnson, Procter & Gamble Co and Colgate-Palmolive Co have said they have either reformulated or are reformulating their products to delete the most common of the 19 ingredients
Read More
FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns
The plant was sold to Frontida in June by Sun, India's No. 1 drugmaker, which said the move was 'a part of its manufacturing consolidation in the US'
Read More
Indoco Remedies Q1 Net Marginally Down At Rs 19.8 Crore
Indoco Remedies on Friday reported a marginal decline in net profit at Rs 19.8 crore for the June quarter against Rs 20.8 crore in the corresponding period last fiscal
Read More
Torrent Pharma Q1 Net Slumps 55% To Rs 292 Crore
Drug firm Torrent Pharmaceuticals has reported 55 per cent fall in consolidated net profit at Rs 292 crore for the June quarter due to a dip in company’s US business
Read More
Sun Pharma Gets US Subpoena Over Generic Drugs Pricing
The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors
Read More
Sanofi Recalls Some Batches Of Painkiller Combiflam In India
Combiflam is a combination of paracetamol and ibuprofen, and is one of Sanofi's five biggest brands in India
Read More
US FDA Warns Sri Krishna Pharma, Citing Drug-data Manipulation
Sri Krishna Pharmaceuticals, a supplier of paracetamol and other drugs to more than 60 countries, has been warned by the US Food and Drug Administration, which cited manipulation of its test results at a plant
Read More
Cadila Gets Negative US FDA Observations For Matoda SEZ Unit
The American regulator had in January issued similar notice to the company's Moraiya manufacturing unit
Read More